New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Jose-Carlos Gutiérrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
-
Do (do.com) Unveils Brand New Mobile Apps for the Apple iPhone and iPad
-
Relevant Health Accelerator Now Recruiting Inaugural Class of Health Tech Startups for Fall 2015
-
ClarVista Announces Series B Financing for Novel Modular IOL
-
Blueshift Wins TiE50 Award, Recognized as a Leading Technology Startup among over 2700 contestants
-
FusionOps Delivers Strong First Quarter 2015 Performance
-
Form SC 13D/A Clovis Oncology, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13D/A TARGACEPT INC Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Cortendo AB: Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing
-
Intact Vascular Secures $38.9 Million in Series B Financing to Accelerate Development of Endovascular Dissection Repair Technology
-
Placester Announces Single Property Sites so Real Estate Professionals Can Grow Business and Stand Out From the Crowd
-
Tech Council of Maryland Names Winners of 27th Annual Industry Awards
-
CORRECTING and REPLACING Tech Council of Maryland Names Winners of 27th Annual Industry Awards
-
SocialRadar Launches LocationKit - the First Replacement for iOS and Android Location Services
-
Form SC 13D/A HYPERION THERAPEUTICS Filed by: New Enterprise Associates 12, Limited Partnership
-
Cartiva, Inc. Closes $8.5 Million Financing
-
Surface Oncology Appoints Detlev Biniszkiewicz as Chief Executive Officer
-
Moximed Closes $33MM Financing Round
-
CIT GAP Funds Invests in e-Kare
-
Cybera Names New CFO and EVP Administration and Secretary
-
Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors
-
Comerica Bank, Glendale Educators and Elected Officials Honor 151 Graduates of Web-Based Financial Education Program
-
Mirna Therapeutics Secures $41.8 Million Series D Financing to Advance Oncology MicroRNA Pipeline
-
CRISPR Therapeutics Raises Additional $64 Million to Translate Breakthrough CRISPR-Cas9 Technology into Next Generation Therapies for Patients
-
UPDATE - DEMO Traction 2015 Successfully Wraps Up San Francisco Conference
-
DEMO Traction 2015 Successfully Wraps Up San Francisco Conference
-
Mirna Therapeutics Presents Interim Phase 1 Data on First-in-Class, First-in-Clinic microRNA-34 Mimic, MRX34, at the 2015 Annual Meeting of the American Association for Cancer Research
-
Blend Therapeutics Presents Preclinical Data for Lead Candidate BTP-114 that Demonstrated Superiority to Cisplatin in Tumor Growth Inhibition
-
Blend Therapeutics Presents Preclinical Data for Lead Pentarin™ Program, BTP-277, Demonstrating Specific and Potent Tumor Cell Targeting for Small-Cell Lung Cancer
-
Ravel Law Announces Unprecedented Judge Analytics Offering
-
IfOnly, the Marketplace for Experiences, Is Offering a Meet & Greet with Justin Bieber and Nick Jonas at the Ultimate Wango Tango Experience on May 9th, 2015
-
Gannett partners with ViewLift to offer digital sports and entertainment video content
-
MEDIAN Technologies: 2014 Results
-
NEA Closes On More Than $3.1B In Committed Capital
-
Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer
-
CashStar Selected as an AlwaysOn OnFinance Top 100 Winner
-
Niara Closes $20m in Series B Funding to Deliver Big Data Security Analytics
-
Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis
-
Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis
-
Form SC 13D/A HYPERION THERAPEUTICS Filed by: New Enterprise Associates 12, Limited Partnership
-
Placester Raises $15 Million in Series B Funding
-
IIX Completes $20 Million Financing With TriplePoint Capital
-
IIX Acquires Leading Interconnection Provider IX Reach
-
IfOnly, the marketplace for experiences, has partnered with the American Red Cross, Get Prepared California, Clear Channel, and iHeart Media to Offer Amazing Experiences for Good
-
ScoreStream scores $2 Million to win the local sports game
-
VytronUS, Inc. Attracts Industry Veteran John Pavlidis as New President and Chief Executive Officer
-
mNectar and Branch Metrics Partner to Bring Optimal User Experience to Mobile Ads
-
Fyusion Closes $13M Venture Round Led by NEA and UTEC
-
Sonatype Named to JMP Securities' Top 50 List of Hottest Privately Held Companies
-
SmartDrive Systems Raises $50 Million and Closes out Record Year

